Name of antibiotic | Bangladesh | Nepal | Tanzania | ||
---|---|---|---|---|---|
Azimpur Tertiary | Kushtia District | Pokhara Regional | Temeke Regional | Muhimbili National | |
N = 106 | N = 303 | N = 344 | N = 213 | N = 49 | |
n (% - CI) | n (% - CI) | n (% - CI) | n (% - CI) | n (% - CI) | |
Amikacin | 4 (3.8 – (1.0–9.4)) | 44 (14.5– (10.7–19.0)) | 55 (16 – (12.2–20.3)) | 0 (0) | 0 (0) |
Ampicillin | 96 (90.6 – (83.3–95.3)) | 0 (0) | 257 (74.7 – (69.7–79.2)) | 135 (63.4 – (56.5–69.8)) | 33 (67.3– (52.4–80.0)) |
Ampicillin-Cloxacillin | 0 (0) | 0 (0) | 0 (0) | 63 (29.6 – (23.5–36.1)) | 0 (0) |
Amoxycillin-Cloxacillin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (2 – (0.0–10.8)) |
Azithromycin | 0 (0) | 1 (0.3 – (0.0–1.8)) | 0 (0) | 0 (0) | 0 (0) |
Aztreonam | 0 (0) | 0 (0) | 1 (0.3 – (0.0–1.6)) | 0 (0) | 0 (0) |
Azoxystrobin (fungicide) | 0 (0) | 4 (1.3 – (0.3–3.3)) | 0 (0) | 0 (0) | 0 (0) |
Cefaclor | 0 (0) | 1 (0.3 – (0.0–1.8)) | 0 (0) | 0 (0) | 0 (0) |
Cefdinir-Flucloxacillin | 0 (0) | 0 (0) | 1 (0.3 – (0.0–1.6)) | 0 (0) | 0 (0) |
Cefixime | 0 (0) | 0 (0) | 23 (6.7 – (4.2–9.8)) | 0 (0) | 0 (0) |
Cephalexin | 0 (0) | 1 (0.3 – (0.0–1.8)) | 0 (0) | 0 (0) | 0 (0) |
Cefotaxime | 0 (0) | 2 (0.7 – (0.0–2.3)) | 38 (11 – (7.9–14.8)) | 1 (0.5 – (0.0–2.5)) | 1 (2 – (0.0–10.8)) |
Ciprofloxacin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (8.2 – (2.2–19.6)) |
Cloxacillin | 2 (1.9 – (0.2–6.6) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Cefepime | 2 (1.9 - (0.2–6.6)) | 1 (0.3 – (0.0–1.8)) | 1 (0.3 – (0.0–1.6)) | 0 (0) | 0 (0) |
Ceftriaxone | 1 (0.9 – (0.02–5.1)) | 19 (6.3 – (3.8–9.6)) | 0 (0) | 9 (4.2 – (1.9–7.8) | 22 (44.9 – (30.6–59.7)) |
Flucloxacillin | 1 (0.9 – (0.02–5.1)) | 11 (3.6 – (1.8–6.4)) | 14 (4.1 – (2.2–6.7)) | 0 (0) | 0 (0) |
Gentamicin | 98 (92.5 – (85.7–96.7) | 217 (71.6 – (66.1–76.6)) | 270 (78.5 – (73.7–82.7)) | 197 (92.5 – (88.0–95.6) | 34 (69.4 – (54.5–81.7)) |
Mexidin | 0 (0) | 1 (0.3 – (0.0–1.8)) | 0 (0) | 0 (0) | 0 (0) |
Metronidazole | 2 (1.9 – (0.2–6.6)) | 56 (18.5 – (14.2–23.3)) | 5 (1.5 – (0.5–3.3)) | 2 (0.9 – (0.1–3.3)) | 5 (10.2 – (3.3–22.2)) |
Moxifloxacin | 0 (0) | 1 (0.3 – (0.0–1.8)) | 0 (0) | 0 (0) | 0 (0) |
Meropenem | 0 (0) | 85 (28.1 – (23.1–33.5)) | 2 (0.6 - (0.0–2.0)) | 0 (0) | 2 (4.1 (0.5–13.9) |
Ofloxacin | 0 (0) | 0 (0) | 1 (0.3 – (0.0–1.6)) | 0 (0) | 0 (0) |
Ceftazidime | 5 (4.7 – (1.5–10.7)) | 210 (69.3 – (63.7–74.4)) | 4 (1.2 – (0.3–2.9) | 0 (0) | 0 (0) |
Tobramycin | 0 (0) | 0 (0) | 2 (0.6 - (0.0–2.0)) | 0 (0) | 0 (0) |
Vancomycin | 0 (0) | 0 (0) | 5 (1.5 – (0.5–3.3)) | 0 (0) | 0 (0) |
Antibiotic - Unspecified | 0 (0) | 8 (2.6 – (1.1–5.1)) | 0 (0) | 0 (0) | 0 (0) |